AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); laboratory coding, pricing, coverage, and payment; Improving Seniors' Timely Access to Care Act (H.R. 3514/S. 1816); Prior Authorization Accountability Act (H.R. 9396); program integrity initiatives.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY BRUGGEN | — |
| LAURA STEVENS KENT | Dep. Chief, Appr. Dir., LD, Sr. LA, Rep. Charlie Dent; LA, Rep. Jim Greenwood |
| DON MAY New | — |
| SUSAN VAN METER | — |
Medical/Disease Research/Clinical Labs MED
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; Enhancing CLIA Act (H.R. 8990); artificial intelligence in laboratory services; Timely Access to Coverage Decisions Act (H.R. 8500); laboratory services as Essential Health Benefits; laboratory coding, pricing, coverage, and payment.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY BRUGGEN | — |
| LAURA STEVENS KENT | Dep. Chief, Appr. Dir., LD, Sr. LA, Rep. Charlie Dent; LA, Rep. Jim Greenwood |
| DON MAY New | — |
| SUSAN VAN METER | — |
Health Issues HCR
Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; Enhancing CLIA Act (H.R. 8990); laboratory services as Essential Health Benefits; Patients Deserve Price Tags Act (H.R. 5582/S. 2355); Lower Costs, More Transparency Act (H.R. 9393); Health Care Price Certainty for All Americans Act (H.R. 9645); Prices on the Wall Act of 2026 (H.R. 9390).
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY BRUGGEN | — |
| LAURA STEVENS KENT | Dep. Chief, Appr. Dir., LD, Sr. LA, Rep. Charlie Dent; LA, Rep. Jim Greenwood |
| DON MAY New | — |
| SUSAN VAN METER | — |
Immigration IMM
H-1Bs for Physicians and Healthcare Workforce Act (H.R. 7961).
| Lobbyist | Covered position, as disclosed |
|---|---|
| HOLLY BRUGGEN | — |
| LAURA STEVENS KENT | Dep. Chief, Appr. Dir., LD, Sr. LA, Rep. Charlie Dent; LA, Rep. Jim Greenwood |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.